Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Bandaram Pharma Packtech Ltd

BANDARAM
BSE
26.37
4.52%
Last Updated:
30 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Bandaram Pharma Packtech Ltd

BANDARAM
BSE
26.37
4.52%
30 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
47Cr
Close
Close Price
26.37
Industry
Industry
Medical Accessories/Disposables
PE
Price To Earnings
90.93
PS
Price To Sales
1.05
Revenue
Revenue
45Cr
Rev Gr TTM
Revenue Growth TTM
7.73%
PAT Gr TTM
PAT Growth TTM
-43.69%
Peer Comparison
How does BANDARAM stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
BANDARAM
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
106771311710881415
Growth YoY
Revenue Growth YoY%
545.0210.636.333.593.7-3.435.9-36.8-28.893.048.4
Expenses
ExpensesCr
10577131169871314
Operating Profit
Operating ProfitCr
010011111101
OPM
OPM%
3.89.26.46.45.44.815.26.66.47.73.46.8
Other Income
Other IncomeCr
000000000000
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
000000001000
PBT
PBTCr
000000100001
Tax
TaxCr
000000000000
PAT
PATCr
000000100000
Growth YoY
PAT Growth YoY%
3,200.0121.9148.0-72.1-38.7157.1458.3-108.3-21.1-88.9-91.03,600.0
NPM
NPM%
3.11.21.61.61.41.69.4-0.11.80.30.42.4
EPS
EPS
0.20.20.10.10.20.10.30.00.10.00.00.1

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
19343745
Growth
Revenue Growth%
81.98.522.1
Expenses
ExpensesCr
18313443
Operating Profit
Operating ProfitCr
1333
OPM
OPM%
6.28.37.65.8
Other Income
Other IncomeCr
0000
Interest Expense
Interest ExpenseCr
0111
Depreciation
DepreciationCr
1111
PBT
PBTCr
0111
Tax
TaxCr
0000
PAT
PATCr
0111
Growth
PAT Growth%
268.04.9-41.6
NPM
NPM%
1.42.82.71.3
EPS
EPS
0.30.80.80.3

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
3121212
Reserves
ReservesCr
0011
Current Liabilities
Current LiabilitiesCr
7121415
Non Current Liabilities
Non Current LiabilitiesCr
8599
Total Liabilities
Total LiabilitiesCr
20323940
Current Assets
Current AssetsCr
15263135
Non Current Assets
Non Current AssetsCr
5685
Total Assets
Total AssetsCr
20323940

Cash Flow

Consolidated
Standalone
Financial YearMar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
-1-4-5
Investing Cash Flow
Investing Cash FlowCr
-5-20
Financing Cash Flow
Financing Cash FlowCr
465
Net Cash Flow
Net Cash FlowCr
-200
Free Cash Flow
Free Cash FlowCr
-4-4-5
CFO To PAT
CFO To PAT%
-426.9-435.7-496.4
CFO To EBITDA
CFO To EBITDA%
-95.4-146.6-174.8

Ratios

Consolidated
Standalone
Financial YearMar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
224456
Price To Earnings
Price To Earnings
155.246.955.9
Price To Sales
Price To Sales
1.21.31.5
Price To Book
Price To Book
7.13.64.4
EV To EBITDA
EV To EBITDA
31.220.125.8
Profitability Ratios
Profitability Ratios
GPM
GPM%
14.819.920.6
OPM
OPM%
6.28.37.6
NPM
NPM%
1.42.82.7
ROCE
ROCE%
4.48.77.7
ROE
ROE%
8.37.77.8
ROA
ROA%
1.33.02.5
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
**Bandaram Pharma Packtech Limited** (formerly known as **Shiva Medicare Limited**) is an Indian listed entity that has undergone a significant strategic pivot. Following an **NCLT order in 2022**, the company transitioned from its legacy operations into the **trading of paper board and recycled waste paper**. Today, it operates as an integrated player in the paper and packaging value chain, leveraging a holding company structure to manage procurement, manufacturing, and distribution. --- ### **Integrated Operational Architecture** The company functions through a synergistic relationship between the parent entity and its subsidiaries, creating a circular supply chain focused on the high-growth packaging segment. * **The Holding-Subsidiary Loop**: Bandaram Pharma Packtech (the parent) primarily handles the procurement and trading of raw materials (recycled waste paper). It supplies these materials to its material subsidiary, **VSR Paper and Packaging Limited**, which converts them into finished paper products for the open market. * **Inter-company Dependency**: The operations are deeply intertwined. In **FY 2024-25**, the holding company sold **57.79%** of its total sales to its subsidiary and sourced **35.99%** of its total purchases from the same subsidiary. * **Book Entry Adjustments**: During **FY 2024-25**, the company adjusted **₹19.6 crore** in debtors and creditors via book entries (offsetting), reflecting the high volume of internal trade without immediate cash realization. --- ### **Strategic Group Structure & Equity Holdings** The group has expanded its footprint through aggressive inorganic growth and equity acquisitions to secure its supply chain. | Entity Name | Relationship | Stake | Core Function | | :--- | :--- | :--- | :--- | | **VSR Paper and Packaging Ltd** | Material Subsidiary | **55%** | Manufacturing of paper products | | **Craftsmart Products Pvt. Ltd** | Wholly Owned Subsidiary | **100%** | Raw material and product sourcing | * **Full Acquisition of Craftsmart (CMPPL)**: In **November 2025**, the company finalized the acquisition of the remaining **84.21%** stake in **CMPPL**. This was executed via a share swap at a ratio of **4:5** (4 Bandaram shares for every 5 CMPPL shares), involving the allotment of **59,71,920 Equity Shares** at **₹20 per share** (including a **₹10 premium**). * **Future Expansion**: Management is actively evaluating further acquisitions in the paper segment and plans to establish a **grading and bailing unit in Bangalore** to enhance material quality and sales volumes. --- ### **Financial Performance & Growth Trajectory** Since its pivot in 2022, the company has moved from a pre-revenue stage to a profitable consolidated entity. * **Consolidated Revenue**: Increased to **₹36.96 crores** in **FY 2024-25**, up from **₹34.11 crores** in **FY 2023-24** and **₹18.73 crores** in **FY 2022-23**. * **Profitability**: Reported a Net Profit After Tax (PAT) of **₹96.78 lakhs** in **FY 2023-24**, reaching **₹99 lakhs** in **FY 2024-25**. * **Subsidiary Contribution**: **VSR Paper and Packaging Ltd** remains the primary engine of growth, contributing **₹35.37 crore** to the consolidated income in **FY 2024-25** with a Profit Before Tax of **₹1.13 crore**. * **Shareholder Returns**: The company recommended a dividend of **₹0.10 per share** for **FY 2023-24**. --- ### **Capital Structure & Financial Backing** To fund its expansion and support its subsidiaries, the company has significantly scaled its financial limits and capital base. * **Equity Capital**: Following a Rights Issue in **July 2023** (allotting **90,00,000 shares** at **₹10**), the paid-up capital stands at **₹12 crore**. The **Authorised Share Capital** was recently increased from **₹12 crore** to **₹19 crore** in **July 2025**. * **Borrowing & Investment Limits**: Shareholders have approved a massive increase in borrowing limits to **₹150 crores** and investment/loan limits (U/s 186) up to **₹100 crores**. * **Subsidiary Support**: * **Corporate Guarantees**: Bandaram increased its guarantee limit for VSR Paper from **₹10 crores** to **₹50 crores** to secure bank funding. * **Direct Lending**: Provided an unsecured loan of **₹2 crore** to its subsidiary in **FY 2024-25**, a significant increase from the **₹50.00 lakhs** provided the previous year. * **Banking Facilities**: The subsidiary maintains credit limits of **₹8.16 crore** with AU Small Finance Bank and has transitioned other loans to **Axis Bank Ltd** under a **₹16.5 crore** guarantee. --- ### **Market Dynamics & Sector Outlook** The company’s strategy is aligned with macro-economic shifts in the Indian packaging industry. * **Regulatory Tailwinds**: Demand is heavily driven by the Indian government’s push to outlaw **single-use plastics**. As state governments implement these bans, the demand for recycled paper packaging from FMCG, F&B, and Pharma sectors is expected to rise. * **Supply Chain Management**: To combat the volatility of raw material prices and the impact of global geopolitical tensions (e.g., Russia-Ukraine), the company utilizes **fixed contracts** with suppliers to secure volumes during peak seasons. * **Seasonality**: Management mitigates seasonal fluctuations in paper board demand by procuring and storing recycled waste paper during non-peak periods, despite the associated **inventory costs**. --- ### **Risk Profile & Auditor Observations** Investors should note specific financial and operational risks identified in recent reports. * **Going Concern & Audit Discrepancies**: Auditors have issued an **Emphasis of Matter** regarding the company’s status as a **Going Concern**. Furthermore, discrepancies were noted in the maintenance of **proper books of account** specifically regarding **sales made through trading activities**. * **Financial Risks**: * **Credit Risk**: Managed via an **Expected Credit Loss (ECL) model** and dealing with creditworthy counterparties. * **Liquidity Risk**: The company relies on a **Risk Management Framework** to ensure earnings predictability and meet short-term obligations. * **Operational Volatility**: The business is sensitive to fluctuations in **crude oil and polymer prices**, which impact the broader packaging market. * **Related Party Transactions**: A significant portion of growth and trade is conducted through entities where promoters hold interests, necessitating rigorous internal oversight.